In particular, we caution you that our forward-looking statements are subject to the ongoing and developing circumstances related to the COVID-19 pandemic, which may have a material adverse effect on our business, operations and future financial results. Copyright 2021 © ACCESSWIRE. A strong clinical emphasis is present throughout this volume from the first section of commonly presenting problems through to the section addressing problems shared with a range of other clinical sub-specialties. In October 2020, Ionis acquired the remaining stake in Akcea Therapeutics and the latter became a wholly owned subsidiary of Ionis. Akcea Therapeutics Akcea Therapeutics is a development and commercialization company focused on helping patients living with serious and rare diseases. Akcea Skyrockets Following Ionis' Acquisition of All Outstanding Shares. Cowen served as financial advisor to the Affiliate Transactions Committee of Akcea's Board of Directors, and Ropes & Gray LLP served as legal counsel to the Affiliate Transactions Committee of Akcea's Board of Directors. Ionis Pharmaceuticals Inc. has agreed to buy the remaining stake in Akcea Therapeutics it did not already own for roughly $500 million, the companies said Aug. 31, in a deal stitched together by . Our platform technology has served as a springboard for drug discovery and realized hope for patients with unmet needs. We are driven by . Copyright � 2021 Surperformance. Ionis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. References Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), is a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious and . To learn more about Ionis visit www.ionispharma.com or follow us on twitter @ionispharma. ACEA Therapeutics General Information Description. Shares of Akcea Therapeutics, Inc. (NASDAQ: AKCA) got a boost, shooting 60% to $18.21. This press release includes forward-looking statements regarding the business of Akcea Therapeutics, Inc. and the therapeutic and commercial potential of AKCEA-ANGPTL3-LRx and other products in development. Cons. To learn more about the BLDR investigation and your rights, go to: The deal will see Ionis pay around $500 million to acquire the 24% of Akcea that it doesn't already own. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx, Therapeutic Modalities and Technology Platforms, Small Molecule Product & Process Development, Maintaining Emotional Well-Being During COVID-19, Reducing Health Disparities in Latino Communities, Creating Cures Through Facility Investments. PHILADELPHIA, Sept. 5, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Akcea Therapeutics, Inc. ("Akcea") (NASDAQ: AKCA) on behalf of the company's shareholders.. On August 31, 2020, Akcea announced that it had entered into an agreement to be acquired by Ionis Pharmaceuticals, Inc. ("Ionis") for $18.15 per share in cash.. About Akcea. Transaction creates a stronger, more efficient company. Akcea is commercializing TEGSEDI® (inotersen) and WAYLIVRA® (volanesorsen) as well as advancing a mature pipeline of novel drugs, including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, AKCEA-APOCIII-LRx, and AKCEA-TTR-LRx, with the potential to treat multiple diseases. Copies of these and other documents are available from the company. This handy practical guide takes this complex subject and puts it into context for the non-specialist. Any statement describing Akcea's or Ionis' goals, expectations, financial or other projections, intentions or beliefs, including the commercial potential of TEGSEDI and WAYLIVRA or other of Akcea's or Ionis' drugs in development is a forward-looking statement and should be considered an at-risk statement.
Mortis Engine Wahapedia, Dog-friendly Beaches In California, Most Eaten Food In The World, Best Japanese Cookies, Shukran Habibti In Arabic, Kpop Concert Singapore 2021, Madejski Stadium Expansion, Weather Luxembourg 15 Days,